首页> 外国专利> METHOD FOR DETECTION OF STRUCTURAL REARRANGEMENTS OF TUMOR CELLS (CHEMERIC GENES) GENOME, DETERMINING SELECTION OF THERAPY AND PREDICTION IN ACUTE LEUKOSIS IN CHILDREN, USING OT-PCR AND SUBSEQUENT HYBRIDIZATION WITH OLIGONUCLEOTIDE BIOLOGICAL MICROCHIP (BIOCHIP)

METHOD FOR DETECTION OF STRUCTURAL REARRANGEMENTS OF TUMOR CELLS (CHEMERIC GENES) GENOME, DETERMINING SELECTION OF THERAPY AND PREDICTION IN ACUTE LEUKOSIS IN CHILDREN, USING OT-PCR AND SUBSEQUENT HYBRIDIZATION WITH OLIGONUCLEOTIDE BIOLOGICAL MICROCHIP (BIOCHIP)

机译:检测肿瘤细胞(化学基因)基因组结构重排的方法,确定儿童急性白血病的治疗选择和预测,使用OT-PCR和随后的寡核苷酸(核苷酸)杂交技术

摘要

FIELD: biotechnology.;SUBSTANCE: method for detection of structural rearrangements of the tumor cells (chimeric genes) genome determining the selection of therapy and prediction in acute leukosis in children, using RT-PCR with subsequent hybridization with an oligonucleotide biological microchip (biochip). Detection of these translocations in the bone marrow tumor cells is the standard of modern diagnosis of leukemia and is used in most modern protocols for patients division to risk groups and selection of therapy, including high-dose cytotoxic drug therapy and/or bone marrow transplantation.;EFFECT: invention allows to identify 22 known chimeric genes.;3 cl, 2 dwg, 3 tbl, 4 ex
机译:领域:生物技术;研究对象:用于检测肿瘤细胞(嵌合基因)基因组结构重排的方法,以确定儿童急性白血病的治疗选择和预测,使用RT-PCR,随后与寡核苷酸生物微芯片(biochip)杂交。骨髓肿瘤细胞中这些易位的检测是现代诊断白血病的标准,并且在大多数现代方案中用于将患者划分为危险组和选择治疗方法,包括大剂量细胞毒性药物治疗和/或骨髓移植。效果:本发明可以鉴定22个已知的嵌合基因; 3 cl,2 dwg,3 tbl,4 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号